Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Nxera Pharma Announces Appointments to Executive Leadership Team
Apr 01, 2025
Contract Type
agreement
TokyoBiotechnologyPharmaceutical
Description
Nxera Pharma Co., Ltd. announces the appointment of Mr. Kiyoshi Kaneko as Chief Commercial Officer and the promotion of Ms. Mariko Nakafuji to Chief Legal Officer
Company Information
Company
Nxera Pharma Ltd
Location
Tokyo, Tokyo, Japan
About
Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally.
In addition to several products being commercialized in Japan, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, and leverages the power of our unique and industry leading GPCR-targeted structure-based drug discovery “NxWave” platform to provide a sustainable source of best- or first-in-class candidates.